Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AST-201 in Advanced Ovarian Cancer
NCT05794659Phase 2Not yet recruiting
- Sponsor
- Aston Sci
- Start
- Jun 2027
- Primary completion
- Dec 2030
- Modality
- RNA Aptamers, Small Molecules, DNA Aptamers
- Countries
- 1
01
Overview
A Phase 2 trial of AST-201 in ovarian cancer, sponsored by Aston Sci. Planned start Jun 2027; status: not yet recruiting.
02
Drugs
AST-201
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT05794659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05794659.